ACCRUE (AMC Clinical Trials at Carolina Ramp Up Enrollment) extends the scope of the Carolina Community Network Center from a focus on breast, colorectal, and prostate cancer disparities to cancers more likely to develop in persons living with HIV/AIDS (PLWHA). With funding from the NCI Center to Reduce Cancer Health Disparities, ACCRUE is identifying and developing strategies to raise awareness of HIV-Related Malignancy Clinical Trials that will ultimately enhance the accrual and retention of PLWHA into the trials.

The ACCRUE team is in partnership with the newly formed AIDS Malignancy Consortium's (AMC) clinical trials site at the University of North Carolina at Chapel Hill (UNC) and is an active member of the AMC Behavioral Research Working Group, one of four working groups, funded by the NCI Office of HIV and AIDS Malignancy (OHAM).

Goals:

  • Develop a network of University and community stakeholders to inform and support the development of behavioral strategies and a system-level intervention to facilitate trial accrual and retention.
     
  • Raise awareness and increase knowledge of AMC clinical trials and HIV/AIDS-related cancers among PLWHA.
MAP MAP MAP MAP